2018 American Transplant Congress
Lab Turnaround Times: A Performance Improvement Project in Post Kidney/Pancreas Transplant Clinic
Purpose:Patients' routine labs, including immunosuppression drug levels, are drawn with each clinic visit starting at 6am.Because the drug levels are not reported by the time…2018 American Transplant Congress
Racing to Activation: Using LEAN Principles to Effectively Manage Your Waitlist with Predicted Improved Outcomes
Introduction: In July 2017, our waitlist was approximately 950 pts, 36% which were inactive. One coordinator & one program assistant managed the kidney waitlist. Review…2018 American Transplant Congress
Greater Access to Kidney Transplantation in Competitive DSAs: Due to Improved Referral?
INTRODUCTION: For patients with chronic kidney disease (CKD), access to kidney transplantation (ATT) varies across the 58 Donor Service Areas (DSAs) of the United States,…2018 American Transplant Congress
De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients Are Highly Responsive to Therapy
Pediatric Nephrology, Lucile Packard Children´s Hospital, Palo Alto, CA.
Background: Pediatric Kidney transplant recipients who develop dnDSAs are at increased risk of allograft loss and rapid decline in GFR. C1q+ DSA, in particular, is…2018 American Transplant Congress
Early Utilization of Telehealth in Kidney Transplantation
Transplant Institute, University Hospitals of Cleveland, Cleveland, OH.
Introduction: Telehealth is an emerging strategy to improve outcomes and decrease emergency department visits and readmissions. Utility of telehealth in kidney transplantation hasn't been much…2018 American Transplant Congress
GDF15 Preventing Renal Ischemia Reperfusion Injury
1University of Western Ontario, London, ON, Canada; 2Jilin University, ChangChun, China.
Rationale: Ischemia reperfusion (I/R) injury still remains one of main causes of early renal dysfunction in kidney transplantation. There are no effective treatments for preventing…2018 American Transplant Congress
Risk of ESRD in Prior Living Kidney Donors
We studied development of End Stage Renal Disease (ESRD) in living kidney donors (LKDs) who donated in the US between 1994 and 2016 (n=123,523), using…2018 American Transplant Congress
Comparison of Microvascular Inflammation in Renal Allograft Tissue between ABO Incompatible and ABO Compatible Kidney Transplantation
Background: Microvascular inflammation (MVI) is considered as a pathological marker for antibody-mediated rejection (AMR) in the presence of donor-specific antibody (DSA). We aimed to investigate…2018 American Transplant Congress
Mortality of Live Kidney Donors in the UK: 15 Year Comparative Cohort Study
To investigate the all-cause mortality o LDs in comparison with healthy controls.Ethics approval was in place to accrue data from database. Protocol reviewed and passed…2018 American Transplant Congress
Hard-To-Place Kidney Offers: Granular Examination of Donor Risk Factors for Discard
Background: Deceased-donor kidney discard rates remain high. Understanding risk factors for discard is difficult since most analyses lack granularity and sufficient sample of high disease…
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 101
- Next Page »